CTLA4 and metastatic melanoma: This patient had been diagnosed with metastatic melanoma, and all relevant treatment options had been exploited, including immune checkpoint inhibition (ICI) with anti-PD1 and the combination of anti-CTLA4 plus anti-PD-1.